Pharmaceutical patent services for companies bringing new drugs to market
Pharmaceutical IP strategy centered on results
Barash Law provides pharmaceutical patent services that help life science teams plan, protect, and monetize innovation. We advise pharmaceutical companies with a global footprint through a virtual model that fits R&D timelines. Our counsel blends chemistry and legal strategy so your portfolio supports fundraising, partnerships, and market exclusivity.
As outside in-house counsel, Barash Law takes responsibility for pharmaceutical patent portfolios: triaging inventions, aligning filings with go-to-market plans, prioritizing what is necessary, and coordinating with trusted firms worldwide. The result is a portfolio that supports licensing, partnerships, and market exclusivity.
Solid-state IP is a niche where experience matters. We help clients identify and claim polymorphs, salts, cocrystals, and amorphous forms with data-driven claims. When lifecycle planning calls for additional protection, we advise on Orange Book–listable substance claims, timing, and coordination with formulation and method claims.
Licensing, agreements, and due diligence
As part of ongoing portfolio counsel, Barash Law supports IP transactions that matter to drug programs. That can include research agreements, collaboration terms, licensing, and investor due diligence on patent assets.
The Fountain at the Landing | Stephanie Come-Ryker
How our process fits R&D and investors
We meet regularly with our client scientists and leadership to map filings to experiments, clinical milestones, and financing timelines. With these inputs and data, we work with management to achieve necessary value.
Where we work and who we serve
Barash Law is based on the outskirts of the Purdue Research Park in Lafayette, Indiana. While we started serving primarily the Purdue startup community, we now serve pharmaceutical companies worldwide. Teams from early discovery through late-stage development work with us on core compound filings, solid form strategies, and prosecution that supports approval and launch.
